Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1544606

registered interest
date	22/11/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rheumatoid Arthritis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many rheumatoid arthritis patients received a biologic in each of the last three years.
tabling member constituency	Makerfield
tabling member printed	Yvonne Fovargue
uin	93513
answer	answer is ministerial correction date of answer 25/11/2022 answer text <p>This information is not collected in the format requested.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 93514 question first answered 25/11/2022 12:58:14 answering member 4527 label Biography information for Helen Whately
tabling member	4034 label Biography information for Yvonne Fovargue

1544608

registered interest
date	22/11/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Rheumatoid Arthritis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many and what proportion of rheumatoid arthritis patients received a biologic in the last 12 months.
tabling member constituency	Makerfield
tabling member printed	Yvonne Fovargue
uin	93514
answer	answer is ministerial correction date of answer 25/11/2022 answer text <p>This information is not collected in the format requested.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 93513 question first answered 25/11/2022 12:58:14 answering member 4527 label Biography information for Helen Whately
tabling member	4034 label Biography information for Yvonne Fovargue

1544610

registered interest
date	22/11/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asthma: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what proportion of severe asthma patients have been prescribed a biologic in the last 12 months.
tabling member constituency	Makerfield
tabling member printed	Yvonne Fovargue
uin	93515
answer	answer is ministerial correction date of answer 29/11/2022 answer text <p>The information on the proportion of severe asthma patients prescribed a biologic is not held in the format requested. However, 3,396 patients commenced a new biologic therapy for severe asthma in the last year. All those patients considered to benefit from a biologic treatment by a specialist severe asthma team will have received the treatment.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 93516 question first answered 29/11/2022 15:37:05 answering member 4527 label Biography information for Helen Whately
tabling member	4034 label Biography information for Yvonne Fovargue

1544613

registered interest
date	22/11/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asthma: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many severe asthma patients were refused biologic treatment in the last 12 months.
tabling member constituency	Makerfield
tabling member printed	Yvonne Fovargue
uin	93516
answer	answer is ministerial correction date of answer 29/11/2022 answer text <p>The information on the proportion of severe asthma patients prescribed a biologic is not held in the format requested. However, 3,396 patients commenced a new biologic therapy for severe asthma in the last year. All those patients considered to benefit from a biologic treatment by a specialist severe asthma team will have received the treatment.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 93515 question first answered 29/11/2022 15:37:05 answering member 4527 label Biography information for Helen Whately
tabling member	4034 label Biography information for Yvonne Fovargue

1491401

registered interest
date	21/07/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he plans to amend the respiratory outcomes section in the update of the NHS Long Term Plan.
tabling member constituency	Makerfield
tabling member printed	Yvonne Fovargue
uin	41993
answer	answer is ministerial correction date of answer 05/09/2022 answer text <p>The Department and NHS England are currently reviewing delivery of the commitments made in the NHS Long Term Plan, including those relating to respiratory outcomes. The update to the NHS Long Term Plan will be published later this year.</p><p>There are no current plans to include metrics measuring uptake of biologics in the NHS Long Term Plan update. However, pathways to biologic therapy are being streamlined, including through the Accelerated Access Collaborative’s work to improve the identification of patients in primary and secondary care settings for referrals to assess suitability to receive biologic treatment.</p> answering member constituency Chichester answering member printed Gillian Keegan grouped question UIN 41994 question first answered 05/09/2022 11:27:51 answering member 4680 label Biography information for Gillian Keegan
tabling member	4034 label Biography information for Yvonne Fovargue

1491402

registered interest
date	21/07/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asthma: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, If he will include metrics on the uptake of biologics for severe asthma in the update to the NHS Long Term Plan.
tabling member constituency	Makerfield
tabling member printed	Yvonne Fovargue
uin	41994
answer	answer is ministerial correction date of answer 05/09/2022 answer text <p>The Department and NHS England are currently reviewing delivery of the commitments made in the NHS Long Term Plan, including those relating to respiratory outcomes. The update to the NHS Long Term Plan will be published later this year.</p><p>There are no current plans to include metrics measuring uptake of biologics in the NHS Long Term Plan update. However, pathways to biologic therapy are being streamlined, including through the Accelerated Access Collaborative’s work to improve the identification of patients in primary and secondary care settings for referrals to assess suitability to receive biologic treatment.</p> answering member constituency Chichester answering member printed Gillian Keegan grouped question UIN 41993 question first answered 05/09/2022 11:27:51 answering member 4680 label Biography information for Gillian Keegan
tabling member	4034 label Biography information for Yvonne Fovargue

1491423

registered interest
date	21/07/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chronic Obstructive Pulmonary Disease: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has plans to include incentives within the Quality and Outcomes Framework or Investment and Impact Fund to help ensure that chronic obstructive pulmonary disease (COPD) patients receive a proactive review of their care after a prescription of oral corticosteroid for a COPD exacerbation.
tabling member constituency	Makerfield
tabling member printed	Yvonne Fovargue
uin	41995
answer	answer is ministerial correction date of answer 05/09/2022 answer text <p>We have no specific plans to do so. However, the Quality and Outcomes Framework and the Investment and Impact Fund are reviewed to ensure alignment with the latest clinical guidance and best practice.</p> answering member constituency Halesowen and Rowley Regis answering member printed James Morris question first answered 05/09/2022 10:38:51 answering member 3992 label Biography information for James Morris
tabling member	4034 label Biography information for Yvonne Fovargue

1491425

registered interest
date	21/07/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chronic Obstructive Pulmonary Disease: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the number of patients who have received all components of the discharge bundle included in the Best Practice Tariff for chronic obstructive pulmonary disease in the last 12 months.
tabling member constituency	Makerfield
tabling member printed	Yvonne Fovargue
uin	41996
answer	answer is ministerial correction date of answer 05/09/2022 answer text <p>No specific estimate has been made. Compliance with the Best Practice Tariff criteria is measured by the National COPD Audit Programme’s secondary care audit.</p><p> </p> answering member constituency Halesowen and Rowley Regis answering member printed James Morris question first answered 05/09/2022 10:40:38 answering member 3992 label Biography information for James Morris
tabling member	4034 label Biography information for Yvonne Fovargue

1491427

registered interest
date	21/07/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Chronic Obstructive Pulmonary Disease: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he has plans to include measures to promote an increase in treatment reviews of chronic obstructive pulmonary disease patients who are risk of exacerbation within CORE20+5.
tabling member constituency	Makerfield
tabling member printed	Yvonne Fovargue
uin	41997
answer	answer is ministerial correction date of answer 05/09/2022 answer text <p>There are no plans to do so. However, Core20PLUS5 supports increasing the uptake of COVID-19, flu and pneumonia vaccines to reduce infective exacerbations and potential emergency hospital admissions.</p> answering member constituency Halesowen and Rowley Regis answering member printed James Morris question first answered 05/09/2022 11:13:19 answering member 3992 label Biography information for James Morris
tabling member	4034 label Biography information for Yvonne Fovargue